Kevin Day, PharmD, is a second-generation independent pharmacist helping to push the cost-plus model forward. In a profile in the November issue of America’s Pharmacist®, we explore how he came to embrace the innovative pricing model and what the transition was like.
Day shares his view on why cost-plus prescription pricing is a sustainable model, how he’s adapted the model to the communities he serves, and the short-term upsides and downsides of making the switch. You can access the magazine landing page here to read the latest issue.
NCPA
